Related Experiment Video
Updated: Jan 26, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model
Ming Chen1, Min Xu2, Chengliang Zhu3
1Department of Blood Transfusion, Zhongnan Hospital of Wuhan University, Wuhan, China.
Abstract:
Hepatocellular carcinoma (HCC) is the third most lethal cancer in the world. Natural killer (NK) cell-mediated immunity is crucial for tumor surveillance and therapy. Characterization of the regulatory mechanisms of NK cell function is important for developing novel immunotherapies against HCC. In this study, we used a chemical-induced mouse HCC model to identify the upregulation of Sirtuin2 (SIRT2) in liver NK cells. In particular, SIRT2 was predominantly expressed in liver CD94+ NK cells. The HCC liver microenvironment induced SIRT2 expression in NK cells. In addition, overexpression of exogenous SIRT2 significantly upregulated the production of cytokines and cytotoxic mediators in activated NK cells. Consistently, SIRT2-overexpressing NK cells showed a stronger tumoricidal effect on hepatoma cells. Moreover, SIRT2 remarkably promoted the phosphorylation of Extracellular-signal-regulated kinase 1/2 (Erk1/2) and p38 Mitogen-activated protein kinases (MAPK) in activated NK cells. SIRT2 knockdown in liver CD94+ NK cells impaired their cytotoxic effect on hepatoma cells. Our study indicates that SIRT2 enhances the tumoricidal activity of liver NK cells in HCC.
Insights
Sirtuin2 (SIRT2) enhances liver Natural Killer (NK) cell activity against hepatocellular carcinoma (HCC). Upregulating SIRT2 in NK cells boosts their tumor-killing ability, offering a potential new avenue for HCC immunotherapy.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide.
- Natural Killer (NK) cell immunity plays a vital role in controlling tumors, including HCC.
- Understanding NK cell regulation is key for developing effective HCC immunotherapies.
Purpose of the Study:
- To investigate the role of Sirtuin2 (SIRT2) in regulating liver NK cell function within the context of HCC.
- To determine if SIRT2 expression impacts NK cell-mediated anti-tumor activity against HCC.
Main Methods:
- Utilized a chemical-induced mouse model of HCC.
- Analyzed SIRT2 expression in liver NK cells, particularly CD94+ NK cells.
- Examined the effects of SIRT2 overexpression and knockdown on NK cell activation, cytokine production, and cytotoxic function.
- Assessed the impact of SIRT2 on MAPK signaling pathways (Erk1/2 and p38).
Main Results:
- Sirtuin2 (SIRT2) was found to be upregulated in liver NK cells during HCC.
- Overexpression of SIRT2 enhanced the production of cytokines and cytotoxic mediators in activated NK cells.
- SIRT2-overexpressing NK cells demonstrated increased tumoricidal activity against hepatoma cells.
- SIRT2 promoted the phosphorylation of Erk1/2 and p38 MAPK in activated NK cells.
- Knockdown of SIRT2 in liver CD94+ NK cells reduced their cytotoxic efficacy against hepatoma cells.
Conclusions:
- Sirtuin2 (SIRT2) enhances the tumoricidal activity of liver NK cells in hepatocellular carcinoma (HCC).
- SIRT2 signaling pathway activation is a critical mechanism for boosting NK cell-mediated anti-tumor immunity in HCC.
- Targeting SIRT2 in NK cells represents a promising strategy for novel HCC immunotherapies.
Related Concept Videos
What is Natural Selection?
Nature and Nurture
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Self-Evaluation: Self-Enhancement and Self-Verification
Chirality in Nature
Bioavailability Enhancement: Drug Solubility Enhancement

